29Sep 2024
Esketamine Reduces Depression After Hip Fracture Surgery

Esketamine Reduces Depression After Hip Fracture Surgery

Esketamine significantly reduced postoperative depression and improved biochemical markers in elderly hip fracture patients. In a randomized, double-blind clinical trial conducted among 90 patients aged ≥65, adjunctive esketamine in patient-controlled intravenous analgesia (PCIA) led to a lower prevalence of depression and reduced Geriatric Depression Scale-15 (GDS-15) scores on postoperative day 2 (28.6% vs. 53.5%, P < 0.05). Additionally, group S showed lower PCIA press counts and higher serum levels of brain-derived neurotrophic factor (BDNF) and 5-hydroxytryptamine (5-HT) compared to the control group. Esketamine also reduced pain intensity and sufentanil consumption. The findings suggest that esketamine, as an adjunct in PCIA, may alleviate depressive symptoms and enhance recovery in elderly patients undergoing hip fracture surgery.

  • #psych
  • #psychiatry

Like

Save

Share